2013, Número 4
<< Anterior Siguiente >>
Rev Endocrinol Nutr 2013; 21 (4)
Incidentaloma adrenal. Presentación de un caso y revisión de la literatura
Rivera-Hernández A, Díaz-Zavala F
Idioma: Español
Referencias bibliográficas: 20
Paginas: 182-186
Archivo PDF: 211.98 Kb.
RESUMEN
La prevalencia del incidentaloma adrenal varía desde 0.1% por ultrasonido hasta 1.9% por tomografía computarizada. Los incidentalomas adrenales producen hormonas en 15% de los casos. En este reporte se presenta el abordaje propuesto para esta patología a través de un caso clínico.
REFERENCIAS (EN ESTE ARTÍCULO)
Linos D: Adrenal incidentaloma (adrenaloma). Hormones. 2003; 2: 12-21.
Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg. 2001; 25: 905-913.
Anagnostis P, Karagiannis A, Tziomalos K, Kakafika AI, Athyros VG, Mikhailidis: Adrenal incidentaloma: a diagnostic challenge. Hormones. 2009; 8: 163-184.
Israel GM, Krinsky GA: MR imaging of kidneys and adrenal glands. Radiol Clin N Am. 2003; 41: 145-159.
Barzon E, Sonino N, Fallo F, Palu G, Boscaro M: Prevalence and natural history of adrenal incidentalomas.
Eur J Endocrinol. 2003; 149: 273-285.
Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006; 29: 298-302.
Rossi R, Tauchmanova L, Luchiano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G: Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab. 2000; 85: 1440-1448.
Ṧtrauch B, Widimskỳ J, Ṧindelka G, Ṧkrha J: Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol Res. 2003; 52: 503-506.
Plouin PF, Duclos JM, Soppelsa F, Boubilil G, Chatellier G: Factors associated with perioperative morbidity and mortality in patient with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab. 2001; 86: 1480-1486.
Fernández-Real JM, Gonzalbez J, Ricat W: Metabolic abnormalities in patients with adrenal incidentaloma. J Clin Endocrinol Metab. 2001; 86: 950b-951b.
Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I: Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf). 2009; 70: 674-679.
Rockall AG, Babar SA, Aslam SA, Isidori AM, Díaz-Cano S, Monson JP, Grossman B, Reznek RH: CT and MR imaging of the adrenal glands in ACTH–independent Cushing syndrome. Radiographics. 2004; 24: 435-452.
Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A: A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab. 2000; 85: 637-644.
Wajchenberg BL, Albergaria PM, Medonca BB, Latronico AC, Campos CP, Ferreira AV, Zerbini MC, Liberman B, Gomes GC, Kirsher MA: Adrenocortical carcinoma. Cancer. 2000; 88: 711-736.
McLean K, Lilienfeld H, Caracciolo JT, Hoffe S, Tourtelot JB, Carter B: Management of isolated adrenal lesions in cancer patients. Cancer Control. 2011; 18: 113-126.
Ahmad N, Kosar T, Rawa IA, Qayum A: Giant adrenal myelolipoma: incidentaloma with a rare incidental association. Urology Annals. 2010; 2: 130-133.
Baid SK, Rubino D, Sinai N, Ramsey S, Frank A, Nieman LK: Specificity of screening tests for Cushing’s syndrome in an overweight and obese population. J Clin Endocrinol Metab. 2009; 94:3864.
Findling JW, Raff H: Screening and diagnosis of Cushing’s syndrome. Endocrinol Metab Clin N Am. 2005; 34: 385-402.
Kapoor A, Morris T, Rebello R: Guidelines for management of the incidentally discovered adrenal mass. Can Urol Assoc J. 2011; 5: 241-247.